ArriVent BioPharma Q3 EPS $(0.83) Misses $(0.81) Estimate

ArriVent BioPharma (NASDAQ: AVBP) reported quarterly losses of $(0.83) per share which missed the analyst consensus estimate of $(0.81) by 2.85 percent. This is a 36.07 percent decrease over losses of $(0.61) per share from the same period last year.